Given that the PI3K/AKT/mTOR pathway plays a role in the pathophysiology of depression (Shi et al., 2012), it is conceivable that artesunate suppresses depressive‐like symptoms by suppressing this pathway. Here, AKT1 is linked to depressive symptom measurement.